Coloplast
Coloplast A/S, a leading global healthcare company headquartered in Denmark (DK), specialises in innovative medical devices and services for individuals with intimate healthcare needs. Founded in 1957, Coloplast has established a strong presence in Europe, North America, and Asia, focusing on areas such as ostomy care, continence care, and wound and skin care. The company is renowned for its commitment to user-friendly products, including advanced ostomy bags and continence management solutions that enhance the quality of life for patients. Coloplast's dedication to research and development has positioned it as a market leader, with notable achievements in product innovation and patient support services. With a strong emphasis on sustainability and social responsibility, Coloplast continues to make significant strides in the healthcare industry, ensuring that individuals receive the best possible care.
DitchCarbon Score
How does Coloplast's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Coloplast's score of 54 is higher than 96% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Coloplast's reported carbon emissions
In 2023, Coloplast reported total greenhouse gas emissions of approximately 223,305,000 kg CO2e, comprising 17,514,000 kg CO2e from Scope 1, 31,427,000 kg CO2e from Scope 2, and 205,708,000 kg CO2e from Scope 3 emissions. This marked a slight increase from 2022, where total emissions were about 219,118,000 kg CO2e. The company has set ambitious climate commitments, aiming to achieve a 100% reduction in absolute Scope 1 and 2 emissions by FY2030, using FY2019 as the baseline. Additionally, Coloplast is committed to sourcing 100% renewable electricity annually through 2025 and aims to reduce Scope 3 emissions by 50% per product manufactured by FY2030. These targets align with the Science Based Targets initiative (SBTi) and reflect Coloplast's dedication to sustainable practices in the healthcare equipment sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 36,404,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 7,398,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Coloplast is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
